Brock N - Search Results

1

Ifosfamide and Mesna in advanced malignancies.

Li GC, Brock N, Li JQ, Guan ZZ, He YJ. Li GC, et al. Among authors: brock n. Chin Med J (Engl). 1988 Mar;101(3):213-20. Chin Med J (Engl). 1988. PMID: 3136996 No abstract available.

2

Treatment of advanced malignancies with ifosfamide under protection with mesna.

Li GC, Brock N, Li JQ, Guan ZZ, He YJ. Li GC, et al. Among authors: brock n. Int J Clin Pharmacol Res. 1988;8(1):55-67. Int J Clin Pharmacol Res. 1988. PMID: 3130316

3

High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.

Klein HO, Wickramanayake PD, Coerper C, Christian E, Pohl J, Brock N. Klein HO, et al. Among authors: brock n. Cancer Treat Rev. 1983 Sep;10 Suppl A:167-73. doi: 10.1016/s0305-7372(83)80025-5. Cancer Treat Rev. 1983. PMID: 6414691 No abstract available.

4

Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.

Manz I, Dietrich I, Przybylski M, Niemeyer U, Pohl J, Hilgard P, Brock N. Manz I, et al. Among authors: brock n. Biomed Mass Spectrom. 1985 Sep;12(9):545-53. doi: 10.1002/bms.1200120918. Biomed Mass Spectrom. 1985. PMID: 2932183

5

The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.

Brock N. Brock N. Recent Results Cancer Res. 1980;74:270-8. doi: 10.1007/978-3-642-81488-4_32. Recent Results Cancer Res. 1980. PMID: 6777836

6

The development of mesna for regional detoxification.

Brock N, Pohl J. Brock N, et al. Cancer Treat Rev. 1983 Sep;10 Suppl A:33-43. doi: 10.1016/s0305-7372(83)80005-x. Cancer Treat Rev. 1983. PMID: 6414694 No abstract available.

7

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).

Brock N, Pohl J, Stekar J, Scheef W. Brock N, et al. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1377-87. doi: 10.1016/0277-5379(82)90143-2. Eur J Cancer Clin Oncol. 1982. PMID: 6819957

8

Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.

Kunze E, Köhnecke B, Engelhardt W, Steinröder H, Brock N, Pohl J. Kunze E, et al. Among authors: brock n. Urol Int. 1984;39(2):61-7. doi: 10.1159/000280947. Urol Int. 1984. PMID: 6426112

9

Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna.

Themann H, Oberdorf E, Brock N, Pohl J. Themann H, et al. Among authors: brock n. Urol Int. 1987;42(1):37-43. doi: 10.1159/000281847. Urol Int. 1987. PMID: 3109094

10

Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

Scheef W, Klein HO, Brock N, Burkert H, Günther U, Hoefer-Janker H, Mitrenga D, Schnitker J, Voigtmann R. Scheef W, et al. Among authors: brock n. Cancer Treat Rep. 1979 Mar;63(3):501-5. Cancer Treat Rep. 1979. PMID: 106965 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters